Skip to content

Network localization of brain functional effects of ketamine treatment for major depression.

Haining Ma, Huaigui Liu, Wenwei Zhang, Xufeng Zhao, Dan Zhang, Kaijie An, Yinfeng Qian, Jiajia Zhu

European psychiatry : the journal of the Association of European Psychiatrists February 13, 2026 DOI: 10.1192/j.eurpsy.2026.10164 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Systematic review with functional connectivity network mapping Longitudinal Peer reviewed
Sample size 508
Population Depressed patients from 16 published ketamine neuroimaging studies, plus 1113 healthy and 255 depressed individuals from large-scale functional MRI datasets
Intervention Ketamine
Topics Depression Ketamine Esketamine
Keywords MRI Brain network Functional connectivity
Key findings Ketamine treatment was associated with increased functional connectivity in subcortical (caudate nucleus, thalamus) and default-mode (medial prefrontal cortex) networks, and decreased connectivity in limbic (temporal pole), subcortical (hippocampus, amygdala), and default-mode (lateral temporal cortex) networks. The authors propose that this network-level mapping may help explain ketamine's antidepressant effects and advance its clinical application.

Abstract

Considerable effort has been devoted to investigate the neuroimaging correlates and predictors of antidepressant response to ketamine, yet inconsistency in the location and nature of the regional brain effects makes it difficult to unify this research. Despite the revolutionary notion that psychiatric therapeutics show network-level brain representations, investigations into network localization of brain functional effects of ketamine treatment are still lacking. We initially identified the locations of longitudinal brain functional alterations (increase and decrease separately) induced by ketamine treatment from 16 published studies with 508 depressed patients. By integrating these affected brain locations with large-scale functional MRI datasets from 1113 healthy and 255 depressed individuals, we then leveraged a novel functional connectivity network mapping approach to construct ketamine-induced hyper-functional and hypo-functional networks respectively. The hyper-functional network mainly involved the subcortical (caudate nucleus and thalamus) and default (medial prefrontal cortex) networks, while its hypo-functional counterpart predominantly implicated the limbic (temporal pole), subcortical (hippocampus and amygdala), and default (lateral temporal cortex) networks. Our findings may shed light on the neurobiological effects of ketamine from a network perspective, which might represent a crucial step toward fostering the clinical application of ketamine in antidepressant treatment.

Comparable studies

Other systematic reviews and meta-analyses on ketamine for depression, most cited first.

Study Year Design Participants
Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression Participants with major depression in placebo-controlled, double-blind, randomized... 2015 Systematic review and meta-analysis
Side-effects associated with ketamine use in depression: a systematic review. Patients with depression 2018 Systematic review
Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis Adults with unipolar or bipolar major depression 2020 Systematic review and meta-analysis n = 1,877
Single-dose infusion ketamine and non-ketamine N-methyl-D-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories Patients with major depressive disorder or bipolar depression 2016 Systematic review and meta-analysis n = 588
The use of ketamine as an antidepressant: a systematic review and meta‐analysis People with major depressive disorder or bipolar disorder receiving ketamine infusion 2015 Meta-analysis n = 437

Explore topics

By condition and practice